Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for sedation in mechanically ventilated ICU patients
NCT04815265Phase 4Unknown
- Sponsor
- Tianjin Nankai Hospital
- Start
- Apr 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of remimazolam in sedation, sponsored by Tianjin Nankai Hospital. Status: unknown.
02
Drugs
remimazolam
03
Conditions
sedation
Beyond the preview
Go deeper on NCT04815265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04815265.